Eugenie Nepovimova Selected Research

T-2 Toxin (T 2 Toxin)

1/2021	Hypoxia, oxidative stress, and immune evasion: a trinity of the trichothecenes T-2 toxin and deoxynivalenol (DON).
11/2020	An update on T-2 toxin and its modified forms: metabolism, immunotoxicity mechanism, and human exposure assessment.
11/2020	The neurotoxicity of trichothecenes T-2 toxin and deoxynivalenol (DON): Current status and future perspectives.
10/2020	Antidotal Potency of the Novel, Structurally Different Adsorbents in Rats Acutely Intoxicated with the T-2 Toxin.
3/2020	Cardiomyopathy induced by T-2 toxin in rats.
10/2019	Efficacy of methylprednisolone on T-2 toxin-induced cardiotoxicity in vivo: A pathohistological study.
12/2017	Trichothecenes: immunomodulatory effects, mechanisms, and anti-cancer potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugenie Nepovimova Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 04/2019 - 12/2010
13	Neoplasms (Cancer) 06/2022 - 01/2014
8	Poisoning 02/2022 - 01/2014
6	COVID-19 01/2022 - 01/2021
5	Inflammation (Inflammations) 01/2022 - 01/2017
5	Infections 01/2022 - 10/2020
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2019
4	Hypoxia (Hypoxemia) 01/2022 - 11/2020
4	Wounds and Injuries (Trauma) 01/2021 - 01/2019
3	Vomiting 01/2021 - 01/2020
3	Amnesia (Dissociative Amnesia) 01/2021 - 01/2018
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 01/2014
2	Amyloid Plaque 01/2022 - 01/2017
2	Body Weight (Weight, Body) 10/2021 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 11/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 11/2020
2	Cardiomyopathies (Cardiomyopathy) 03/2020 - 10/2019
2	Cardiotoxicity 03/2020 - 10/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2017
2	Narcolepsy 01/2019 - 11/2018
2	Dementia (Dementias) 01/2019 - 01/2019
2	Sleep Wake Disorders 01/2019 - 11/2018
1	Kashin-Beck Disease 06/2022
1	Carcinogenesis 02/2022
1	Autism Spectrum Disorder 01/2022
1	Plague (Bubonic Plague) 01/2022
1	Organophosphate Poisoning 12/2021
1	Mycoses (Diseases, Fungus) 05/2021
1	Bacterial Infections (Bacterial Infection) 02/2021

Drug/Important Bio-Agent (IBA)

9	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2018 - 12/2010
8	Tacrine (Cognex)FDA Link 01/2021 - 11/2011
7	T-2 Toxin (T 2 Toxin)IBA 01/2021 - 12/2017
5	MycotoxinsIBA 02/2022 - 03/2020
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2016
4	OximesIBA 11/2019 - 01/2014
3	AntioxidantsIBA 05/2022 - 12/2018
3	CytokinesIBA 01/2022 - 08/2018
3	AcetylcholinesteraseIBA 01/2021 - 01/2018
3	LigandsIBA 01/2021 - 11/2018
3	deoxynivalenolIBA 01/2021 - 01/2021
3	TrichothecenesIBA 01/2021 - 12/2017
3	Memantine (Namenda)FDA Link 01/2019 - 06/2014
3	Phosphotransferases (Kinase)IBA 01/2016 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2014
2	PhytochemicalsIBA 07/2022 - 05/2021
2	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 04/2020
2	VaccinesIBA 01/2022 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2020
2	Nerve AgentsIBA 12/2021 - 01/2018
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021 - 01/2020
2	OxidesIBA 01/2021 - 01/2021
2	Granisetron (Kytril)FDA LinkGeneric 01/2021 - 01/2020
2	neuropeptide Y2 receptorIBA 01/2021 - 01/2020
2	Scopolamine (Hyoscine)FDA Link 01/2021 - 04/2019
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2020
2	EndotoxinsIBA 09/2020 - 01/2019
2	Simvastatin (Zocor)FDA LinkGeneric 09/2020 - 01/2019
2	Antidepressive Agents (Antidepressants)IBA 04/2020 - 01/2019
2	diacetoxyscirpenolIBA 01/2020 - 12/2017
2	trichotheceneIBA 01/2020 - 12/2017
2	Obidoxime Chloride (Obidoxime)IBA 11/2019 - 09/2018
2	Therapeutic UsesIBA 01/2019 - 04/2018
2	6-chlorotacrineIBA 01/2019 - 01/2018
2	OrexinsIBA 01/2019 - 11/2018
2	Donepezil (Aricept)FDA LinkGeneric 01/2019 - 12/2018
2	Cholinesterases (Cholinesterase)IBA 01/2017 - 01/2016
2	Biological ProductsIBA 01/2017 - 11/2015
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2014 - 01/2014
2	DNA-Activated Protein KinaseIBA 10/2014 - 01/2014
1	Aggrecans (Aggrecan)IBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	CoagulantsIBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	dimethylglycineIBA 01/2022
1	poly(tetramethylene succinate-co-tetramethylene adipate)IBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Stem Cell FactorIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	ZearalenoneIBA 01/2022
1	favipiravirIBA 10/2021
1	Disinfectants (Biocides)IBA 10/2021
1	Virus-Like Particle VaccinesIBA 10/2021
1	Surface-Active Agents (Surfactants)IBA 10/2021
1	AflatoxinsIBA 10/2021
1	Tight Junction ProteinsIBA 10/2021
1	Long Noncoding RNAIBA 09/2021
1	remdesivirIBA 03/2021
1	Sirolimus (Rapamycin)FDA Link 03/2021
1	tilmicosinIBA 02/2021

Therapy/Procedure

11	Therapeutics 03/2021 - 01/2014
2	Immunotherapy 01/2022 - 01/2021
1	Traditional Medicine (Folk Remedies) 07/2022
1	Personal Protective Equipment 10/2021